EC Clinical and Medical Case Reports

Serum vitamin D deficiency or insufficiency has been observed to play a role as a risk factor in the development of infectious processes and the degree of morbidity thereof. This relationship has been attributed to the extra-skeletal actions of vitamin D through immunomodulatory mechanisms.

We conducted a systematic literature review and cross-sectional retrospective case studies, which confirmed this inverse correlation between hypovitaminosis D and specific infections (Pneumonia, urinary tract infection, cellulitis) in our primary care setting, which could be used as a basis for prognostic evaluation.

 Keywords: Vitamin D Deficiency; Infection; Pneumonia; UTI; Cellulitis

1. Upala S., et al. “Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis”. BMC Anesthesiology 15 (2015): 84.
2. Zhou W., et al. “Association between vitamin D status and sepsis”. Clinical Laboratory4 (2018): 451-460.
3. de Haan K., et al. “Vitamin D deficiency as a risk factor for infection, sepsis, and mortality in the critically ill: systematic review and meta-analysis”. Critical Care6 (2014): 660.
4. Fraser DR. “Regulation of the metabolism of vitamin D”. Physiological Reviews2 (1980): 551-613.
5. German Nutrition Society, Bonn, Germany. “New reference values for vitamin D”. Annals of Nutrition and Metabolism 4 (2012): 241-246.
6. Fabregat-Bolufer AB., et al. “Redefining vitamin D Status: Establishing Population-Based indirect reference intervals through big data analysis”. Clinica Chimica Acta 569 (2025): 120155.
7. Hussain F., et al. “Assessment of vitamin D levels and bone-related biochemical markers in healthy adults in pakistan: influence of socio-demographic and environmental factors: vitamin D levels and bone-related biochemical markers in healthy adults”. Pakistan Journal of Health Sciences3 (2025): 194-199.
8. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). “Dietary reference values for vitamin D”. EFSA Journal10 (2016): e04547.
9. Ibrahim R. “Vitamin D deficiency in the setting of multiple sclerosis-a case report and literature review”. EC Cardiology10 (2020): 54-59.
10. Ibrahim R. “The relationship of vitamin D deficiency to prediabetes and diabetes control-a systematic review”. EC Clinical and Medical Case Reports12 (2024): 01-06.
11. Muszkat P., et al. “Evidence-based non-skeletal actions of vitamin D”. Arquivos Brasileiros de Endocrinologia and Metabologia2 (2010): 110-117.
12. Holick MF. “The vitamin D deficiency pandemic and consequences for non-skeletal health: mechanisms of action”. Molecular Aspects of Medicine6 (2008): 361-368.
13. Bivona G., et al. “Non-skeletal activities of vitamin D: from physiology to brain pathology”. Medicina7 (2019): 341.
14. Masood R., et al. “Microbial etiology of pneumonia: epidemiology, diagnosis, and resistance pattern”. Pakistan Journal of Medical and Health Sciences8 (2022): 846-849.
15. Ismailova A and White JH. “Vitamin D, infections, and immunity”. Reviews in Endocrine and Metabolic Disorders 2 (2022): 265-277.
16. Sarhan TS and Elrifai A. “Serum level of vitamin D as a predictor for severity and outcome of pneumonia”. Clinical Nutrition4 (2021): 2389-2393.
17. Oktaria V., et al. “Vitamin D deficiency and severity of pneumonia in Indonesian children”. Plos one7 (2021): e0254488.
18. Grant WB., et al. “Vitamin D supplementation could prevent and treat influenza, coronavirus, and pneumonia infections”. Nutrients 4 (2020): 988.
19. Jovanovich AJ., et al. “Vitamin D level and risk of community-acquired pneumonia and sepsis”. Nutrients6 (2014): 2196-2205.
20. Ibrahim R., et al. “Positive response of vitamin D therapy in conjunction with conventional treatments of reactive airways dysfunction syndrome (RADS)”. British Journal of Medicine and Medical Research4 (2013).
21. Akeredolu FD., et al. “Relationship between serum vitamin D levels and acute pneumonia in children aged 1–59 months in Nigeria”. Journal of Tropical Pediatrics1 (2021): fmaa101.
22. Kalembang CN., et al. “Vitamin D insufficiency as risk factor of severe pneumonia in children”. GSC Advanced Research and Reviews2 (2021): 58-65.
23. Rashad,ML., et al. “Vitamin D status in infants, toddlers, and preschool children with pneumonia”. Zagazig University Medical Journal8 (2024): 4476-4482.
24. Zhang K., et al. “Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019”. World Journal of Urology3 (2022): 755-763.
25. Tan CW and Chlebicki MP. “Urinary tract infections in adults”. Singapore Medical Journal9 (2016): 485-490.
26. Yang X., et al. “Disease burden and long-term trends of urinary tract infections: a worldwide report”. Frontiers in Public Health 10 (2022): 888205.
27. Çağlar S., et al. “Investigating the 25 (OH) vitamin D levels and impacts of urinary tract infection in geriatric hematogenous septic arthritis patients”. Bagcilar Medical Bulletin3 (2023): 310-316.
28. Pirdel L and Pirdel M. “A differential immune modulating role of vitamin D in urinary tract infection”. Immunological Investigations3 (2022): 531-545.
29. Raff AB and Kroshinsky D. “Cellulitis: a review”. Journal of the American Medical Association3 (2016): 325-337.
30. Ong BS., et al. “Recurrent cellulitis: who is at risk and how effective is antibiotic prophylaxis?”. International Journal of General Medicine 15 (2022): 6561-6572.